Dec. 4, 2023, 10:35 p.m. | Katyanna Quach

The Register - Software: AI + ML www.theregister.com

Startup Absci will turn to its generative AI algorithms to design synthetic protein

Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer.…

absci ai algorithms algorithms astrazeneca cancer deal design generative pharma protein startup synthetic will

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Software Engineering Manager, Generative AI - Characters

@ Meta | Bellevue, WA | Menlo Park, CA | Seattle, WA | New York City | San Francisco, CA

Senior Operations Research Analyst / Predictive Modeler

@ LinQuest | Colorado Springs, Colorado, United States